Active principles

Pharmaceutical Forms for parenteral use. "5.625 mg / 3 ml solution for injection" 1 ampoule of 3 ml contains: polydeoxyribonucleotide 5.625 mg. "2.25 mg / 3 ml solution for injection" 1 ampoule of 3 ml contains: polydeoxyribonucleotide 2.25 mg. Pharmaceutical forms for external use. "0.08% cream" 25 g tube contains: 80 mg polydeoxyribonucleotide. "0.75 mg / 3 ml cutaneous solution" 1 ampoule of 3 ml contains: polydeoxyribonucleotide 0.75 mg. "0.75 mg / ml eye drops" one dropper bottle of 10 ml contains: polydeoxyribonucleotide 7.5 mg.

Excipients

"5.625 mg / 3ml solution for injection": sodium chloride; ppi water "2.25 mg / 3ml solution for injection": sodium chloride; ppi water "0.08% cream": esters of oleic acid of decyl alcohol, cetylstearyl alcohol, anhydrous lanolin, alkyl p-hydroxy benzoates, imidazolidinylurea, aromatic base, purified water. "0.75 mg / 3ml cutaneous solution" sodium chloride; ppi water "0.75 mg / ml eye drops" polyvinylpyrrolidone, methyl-p-hydroxy benzoate, propyl-p-hydroxy benzoate, sodium edetate, monobasic sodium phosphate, dibasic sodium phosphate, ppi water

Indications

For parenteral use. "5.625 mg / 3ml solution for injection", "2.25 mg / 3ml solution for injection" Connective disorders on a dystrophic or dystrophic-ulcerative basis: healing, antidystrophic. For external use. "0.08% cream". Skin and connective tissue disorders on a dystrophic or dystrophic-ulcerative basis: healing, antidystrophic. "0.75 mg / 3ml cutaneous solution". Connective disorders based on dystrophic or ulcerative dystrophic: healing, antidystrophic. "0.75 mg / ml eye drops". Diseases on a dystrophic-ulcerative basis of the conjunctiva and cornea: microtrauma from contact lenses, healing.

Contraindications / Side Effects

Hypersensitivity 'to the active substance or to one of the excipients.

Dosage

"5.625 mg / 3ml solution for injection", "2.25 mg / 3ml solution for injection" 1 ampoule by the intramuscular or subcutaneous route, for cycles of 15-20 days repeatable or according to medical prescription. "0.08% cream" local applications once or twice or according to medical prescription. "0.75 mg / 3 ml cutaneous solution" local applications 1 or 2 times a day, soaking sterile gauze or according to medical prescription. "0.75mg / ml eye drops" 2 or 3 drops in the conjunctival fornix 2-4 times or according to medical prescription.

storage

No special storage precautions. Keep away from heat sources and protected from light.

Warnings

The product is neither addictive nor risk of drug addiction. In case of subjective hypersensitivity to the component, suspend the administration and, if necessary, initiate medical desensitizing therapy. No particular precautions for use emerged.

Interactions

No interaction studies have been performed.

Side effects

Report any suspected adverse reactions via the national reporting system of the Italian Medicines Agency.

Pregnancy and breastfeeding

There are no or limited data on use in pregnant women.